questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Oxidoreductases
Superoxide dismutase
Superoxide dismutase : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Désordres enzymatiques
Superoxyde dismutase
Tests de laboratoire
Superoxyde dismutase
Génétique
Superoxyde dismutase
Symptômes
Superoxyde dismutase
Biopsie
Superoxyde dismutase
Symptômes
5
Symptômes
Superoxyde dismutase
Douleur
Superoxyde dismutase
Symptômes respiratoires
Superoxyde dismutase
Troubles neurologiques
Superoxyde dismutase
Santé de la peau
Superoxyde dismutase
Prévention
5
Prévention
Superoxyde dismutase
Mode de vie
Superoxyde dismutase
Toxines
Superoxyde dismutase
Stress oxydatif
Superoxyde dismutase
Compléments alimentaires
Superoxyde dismutase
Traitements
5
Traitement
Superoxyde dismutase
Antioxydants
Superoxyde dismutase
Thérapie génique
Superoxyde dismutase
Médicaments
Superoxyde dismutase
Nutrition
Superoxyde dismutase
Complications
5
Complications
Superoxyde dismutase
Cancer
Superoxyde dismutase
Maladies respiratoires
Superoxyde dismutase
Maladies cardiovasculaires
Superoxyde dismutase
Vieillissement
Superoxyde dismutase
Facteurs de risque
5
Facteurs de risque
Superoxyde dismutase
Nutrition
Superoxyde dismutase
Tabagisme
Superoxyde dismutase
Stress
Superoxyde dismutase
Maladies héréditaires
Superoxyde dismutase
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Superoxide dismutase : Questions médicales les plus fréquentes",
"headline": "Superoxide dismutase : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Superoxide dismutase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-17",
"dateModified": "2025-02-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Superoxide dismutase"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Oxidoreductases",
"url": "https://questionsmedicales.fr/mesh/D010088",
"about": {
"@type": "MedicalCondition",
"name": "Oxidoreductases",
"code": {
"@type": "MedicalCode",
"code": "D010088",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Superoxide dismutase-1",
"alternateName": "Superoxide Dismutase-1",
"url": "https://questionsmedicales.fr/mesh/D000072105",
"about": {
"@type": "MedicalCondition",
"name": "Superoxide dismutase-1",
"code": {
"@type": "MedicalCode",
"code": "D000072105",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.881.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Superoxide dismutase",
"alternateName": "Superoxide Dismutase",
"code": {
"@type": "MedicalCode",
"code": "D013482",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Paulo R Mouro",
"url": "https://questionsmedicales.fr/author/Paulo%20R%20Mouro",
"affiliation": {
"@type": "Organization",
"name": "São Paulo State University (UNESP), IBILCE , São José do Rio Preto 15054-000 , Brazil."
}
},
{
"@type": "Person",
"name": "Vitor B P Leite",
"url": "https://questionsmedicales.fr/author/Vitor%20B%20P%20Leite",
"affiliation": {
"@type": "Organization",
"name": "São Paulo State University (UNESP), IBILCE , São José do Rio Preto 15054-000 , Brazil."
}
},
{
"@type": "Person",
"name": "Jorge Chahine",
"url": "https://questionsmedicales.fr/author/Jorge%20Chahine",
"affiliation": {
"@type": "Organization",
"name": "São Paulo State University (UNESP), IBILCE , São José do Rio Preto 15054-000 , Brazil."
}
},
{
"@type": "Person",
"name": "Mehtap Bayır",
"url": "https://questionsmedicales.fr/author/Mehtap%20Bay%C4%B1r",
"affiliation": {
"@type": "Organization",
"name": "Department of Agricultural Biotechnology, Faculty of Agriculture, Atatürk University, Erzurum, Turkey."
}
},
{
"@type": "Person",
"name": "Erdal Özdemir",
"url": "https://questionsmedicales.fr/author/Erdal%20%C3%96zdemir",
"affiliation": {
"@type": "Organization",
"name": "Department of Agricultural Biotechnology, Faculty of Agriculture, Atatürk University, Erzurum, Turkey."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The prevalence of clarithromycin-resistant",
"datePublished": "2023-03-30",
"url": "https://questionsmedicales.fr/article/37016679",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7717/peerj.15121"
}
},
{
"@type": "ScholarlyArticle",
"name": "Vonoprazan With Amoxicillin or Amoxicillin and Clarithromycin for the Treatment of",
"datePublished": "2023-01-23",
"url": "https://questionsmedicales.fr/article/36688309",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10600280221149708"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Vonoprazan, Clarithromycin, and Metronidazole Regimen as Helicobacter pylori Eradication Therapy for Patients with Penicillin Allergy in Light of Clarithromycin Resistance.",
"datePublished": "2023-01-12",
"url": "https://questionsmedicales.fr/article/36631092",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2169/internalmedicine.0789-22"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effective Eradication Regimen and Duration According to the Clarithromycin Susceptibility of",
"datePublished": "2022-09-28",
"url": "https://questionsmedicales.fr/article/36168964",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.5009/gnl220256"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clarithromycin-based Helicobacter pylori eradication therapy is not associated with higher treatment failure compared with non-clarithromycin-based regimens in a tertiary referral hospital in Switzerland.",
"datePublished": "2023-01-07",
"url": "https://questionsmedicales.fr/article/36652712",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.57187/smw.2023.40024"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Oxidoreductases",
"item": "https://questionsmedicales.fr/mesh/D010088"
},
{
"@type": "ListItem",
"position": 5,
"name": "Superoxide dismutase",
"item": "https://questionsmedicales.fr/mesh/D013482"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Superoxide dismutase - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Superoxide dismutase",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-01",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Superoxide dismutase",
"description": "Comment diagnostiquer une déficience en SOD ?\nQuels tests sont utilisés pour évaluer la SOD ?\nLa génétique joue-t-elle un rôle dans le diagnostic ?\nQuels symptômes peuvent indiquer un problème de SOD ?\nPeut-on mesurer la SOD dans les tissus ?",
"url": "https://questionsmedicales.fr/mesh/D013482?mesh_terms=Clarithromycin#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Superoxide dismutase",
"description": "Quels sont les symptômes d'une déficience en SOD ?\nLa déficience en SOD cause-t-elle des douleurs ?\nY a-t-il des symptômes respiratoires associés ?\nLes troubles neurologiques sont-ils fréquents ?\nLa déficience en SOD affecte-t-elle la peau ?",
"url": "https://questionsmedicales.fr/mesh/D013482?mesh_terms=Clarithromycin#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Superoxide dismutase",
"description": "Comment prévenir les déficiences en SOD ?\nLe mode de vie influence-t-il la SOD ?\nLes toxines environnementales affectent-elles la SOD ?\nLe stress oxydatif peut-il être évité ?\nLes compléments alimentaires sont-ils utiles ?",
"url": "https://questionsmedicales.fr/mesh/D013482?mesh_terms=Clarithromycin#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Superoxide dismutase",
"description": "Quels traitements existent pour la déficience en SOD ?\nLes antioxydants aident-ils à compenser la déficience ?\nLa thérapie génique est-elle une option ?\nDes médicaments spécifiques existent-ils ?\nLes changements alimentaires peuvent-ils aider ?",
"url": "https://questionsmedicales.fr/mesh/D013482?mesh_terms=Clarithromycin#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Superoxide dismutase",
"description": "Quelles complications peuvent survenir avec une déficience en SOD ?\nLa déficience en SOD augmente-t-elle le risque de cancer ?\nDes maladies respiratoires peuvent-elles être liées ?\nLes maladies cardiovasculaires sont-elles un risque ?\nY a-t-il un lien avec le vieillissement prématuré ?",
"url": "https://questionsmedicales.fr/mesh/D013482?mesh_terms=Clarithromycin#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Superoxide dismutase",
"description": "Quels sont les facteurs de risque pour une déficience en SOD ?\nL'alimentation influence-t-elle la SOD ?\nLe tabagisme affecte-t-il la SOD ?\nLe stress chronique est-il un facteur de risque ?\nLes maladies héréditaires influencent-elles la SOD ?",
"url": "https://questionsmedicales.fr/mesh/D013482?mesh_terms=Clarithromycin#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en SOD ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins mesurant l'activité de la SOD peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la SOD ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques et des analyses biochimiques sont utilisés pour évaluer la SOD."
}
},
{
"@type": "Question",
"name": "La génétique joue-t-elle un rôle dans le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests génétiques peuvent identifier des mutations affectant la SOD."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème de SOD ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fatigue, des douleurs musculaires et des troubles neurologiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Peut-on mesurer la SOD dans les tissus ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des biopsies peuvent être analysées pour mesurer l'activité de la SOD dans les tissus."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une déficience en SOD ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, faiblesse musculaire et troubles neurologiques."
}
},
{
"@type": "Question",
"name": "La déficience en SOD cause-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs musculaires et des crampes peuvent être présentes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes respiratoires associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des problèmes respiratoires peuvent survenir en raison de l'oxydation cellulaire accrue."
}
},
{
"@type": "Question",
"name": "Les troubles neurologiques sont-ils fréquents ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles neurologiques comme des pertes de mémoire peuvent se manifester."
}
},
{
"@type": "Question",
"name": "La déficience en SOD affecte-t-elle la peau ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des problèmes cutanés comme le vieillissement prématuré peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Comment prévenir les déficiences en SOD ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et riche en antioxydants peut aider à prévenir les déficiences."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il la SOD ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain, incluant l'exercice, peut améliorer l'activité de la SOD."
}
},
{
"@type": "Question",
"name": "Les toxines environnementales affectent-elles la SOD ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition aux toxines peut réduire l'activité de la SOD dans l'organisme."
}
},
{
"@type": "Question",
"name": "Le stress oxydatif peut-il être évité ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Réduire le stress oxydatif par des antioxydants peut aider à préserver la SOD."
}
},
{
"@type": "Question",
"name": "Les compléments alimentaires sont-ils utiles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains compléments peuvent soutenir la fonction antioxydante de la SOD."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour la déficience en SOD ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments antioxydants et des thérapies géniques peuvent être envisagés."
}
},
{
"@type": "Question",
"name": "Les antioxydants aident-ils à compenser la déficience ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antioxydants peuvent réduire les dommages oxydatifs en cas de déficience en SOD."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie génique vise à corriger les mutations affectant la SOD."
}
},
{
"@type": "Question",
"name": "Des médicaments spécifiques existent-ils ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de médicaments spécifiques pour traiter la déficience en SOD."
}
},
{
"@type": "Question",
"name": "Les changements alimentaires peuvent-ils aider ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en antioxydants peut soutenir la fonction de la SOD."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une déficience en SOD ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des maladies neurodégénératives et des troubles cardiovasculaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "La déficience en SOD augmente-t-elle le risque de cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une déficience en SOD peut augmenter le risque de développement de certains cancers."
}
},
{
"@type": "Question",
"name": "Des maladies respiratoires peuvent-elles être liées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies respiratoires comme l'asthme peuvent être exacerbées par une déficience en SOD."
}
},
{
"@type": "Question",
"name": "Les maladies cardiovasculaires sont-elles un risque ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une déficience en SOD peut contribuer à des maladies cardiovasculaires en augmentant le stress oxydatif."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien avec le vieillissement prématuré ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une activité réduite de la SOD est associée au vieillissement prématuré des cellules."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour une déficience en SOD ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, l'exposition à des toxines et le vieillissement."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle la SOD ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation pauvre en antioxydants peut augmenter le risque de déficience en SOD."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il la SOD ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente le stress oxydatif et peut réduire l'activité de la SOD."
}
},
{
"@type": "Question",
"name": "Le stress chronique est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut diminuer l'activité de la SOD et augmenter les dommages cellulaires."
}
},
{
"@type": "Question",
"name": "Les maladies héréditaires influencent-elles la SOD ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies génétiques peuvent affecter la production ou l'activité de la SOD."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 11/02/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
São Paulo State University (UNESP), IBILCE , São José do Rio Preto 15054-000 , Brazil.
Publications dans "Superoxide dismutase" :
2 publications dans cette catégorie
Affiliations :
São Paulo State University (UNESP), IBILCE , São José do Rio Preto 15054-000 , Brazil.
Center for Theoretical Biological Physics , Rice University , Houston , Texas 77005 , United States.
Publications dans "Superoxide dismutase" :
2 publications dans cette catégorie
Affiliations :
São Paulo State University (UNESP), IBILCE , São José do Rio Preto 15054-000 , Brazil.
Publications dans "Superoxide dismutase" :
2 publications dans cette catégorie
Affiliations :
Department of Agricultural Biotechnology, Faculty of Agriculture, Atatürk University, Erzurum, Turkey.
Publications dans "Superoxide dismutase" :
2 publications dans cette catégorie
Affiliations :
Department of Agricultural Biotechnology, Faculty of Agriculture, Atatürk University, Erzurum, Turkey.
Publications dans "Superoxide dismutase" :
2 publications dans cette catégorie
Affiliations :
Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Publications dans "Superoxide dismutase" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India. prashantdops@gmail.com.
Centre for Transdisciplinary Research, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Science, Chennai, India. prashantdops@gmail.com.
Publications dans "Superoxide dismutase" :
2 publications dans cette catégorie
Affiliations :
Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. amir_saheb2000@yahoo.com.
Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. amir_saheb2000@yahoo.com.
Department of Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. amir_saheb2000@yahoo.com.
Publications dans "Superoxide dismutase" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry, University of Allahabad, Allahabad, India.
Publications dans "Superoxide dismutase" :
2 publications dans cette catégorie
Affiliations :
Molecular Biophysics Group, Institute of Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, L69 7ZB, UK.
Publications dans "Superoxide dismutase" :
2 publications dans cette catégorie
Affiliations :
Department of Advanced Biomedical Sciences, Medical School, "Federico II" University of Naples, Naples, Italy.
Publications dans "Superoxide dismutase" :
2 publications dans cette catégorie
Affiliations :
Department of Histopathology, Imperial College London, Hammersmith Hospital, London, United Kingdom.
Publications dans "Superoxide dismutase" :
2 publications dans cette catégorie
Affiliations :
Department of Advanced Biomedical Sciences, Medical School, "Federico II" University of Naples, Naples, Italy.
Publications dans "Superoxide dismutase" :
1 publication dans cette catégorie
Affiliations :
Department of Food and Nutrition, Brian Korea 21 PLUS Project, College of Human Ecology, Yonsei University, Seoul, Korea.
Publications dans "Superoxide dismutase" :
1 publication dans cette catégorie
Affiliations :
Department of Food and Nutrition, Brian Korea 21 PLUS Project, College of Human Ecology, Yonsei University, Seoul, Korea.
Publications dans "Superoxide dismutase" :
1 publication dans cette catégorie
Affiliations :
Department of Food and Nutrition, Brian Korea 21 PLUS Project, College of Human Ecology, Yonsei University, Seoul, Korea.
Publications dans "Superoxide dismutase" :
1 publication dans cette catégorie
Affiliations :
Department of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4C, 03601 Martin, Slovakia. kopincova@jfmed.uniba.sk.
Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4C, 03601 Martin, Slovakia. kopincova@jfmed.uniba.sk.
Publications dans "Superoxide dismutase" :
1 publication dans cette catégorie
Affiliations :
Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4C, 03601 Martin, Slovakia. maros.kolomaznik@uniba.sk.
Publications dans "Superoxide dismutase" :
1 publication dans cette catégorie
Affiliations :
Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4C, 03601 Martin, Slovakia. pavol.mikolka@jfmed.uniba.sk.
Publications dans "Superoxide dismutase" :
1 publication dans cette catégorie
Affiliations :
Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4C, 03601 Martin, Slovakia. petra.kosutova@jfmed.uniba.sk.
Publications dans "Superoxide dismutase" :
Knowledge of global clarithromycin (CLA)-resistant rates of...
A comprehensive search was performed for relevant literature until April 2021 in PubMed, Embase, and Web of Science databases. Freeman-Tukey double arcsine transformation was performed to estimate the...
The meta-analysis included 248 articles. The prevalence of CLA-resistant...
Overall CLA resistance rate was 27.53%, worldwide. The difference in CLA resistance rate among the included studies can be due to several reasons such as differences in antibiotic prescription rates i...
To describe the pharmacology, efficacy, safety, and potential role of vonoprazan with amoxicillin or amoxicillin and clarithromycin for the treatment of...
PubMed, Embase, Cochrane Library, and ClinicalTrials.gov were searched using the terms: (vonoprazan OR voquezna) AND ("...
Studies assessing the efficacy and safety of vonoprazan with amoxicillin and/or clarithromycin were included and divided into 3 groups based on different comparisons between treatment regimens used in...
Ten clinical trials and 17 observational studies were included. Vonoprazan-based therapy demonstrated greater acid inhibition and similar or higher efficacy than proton-pump inhibitor (PPI)-based ther...
Proton-pump inhibitor-based therapies have not reached the desired successful eradication rate of 90% for...
Vonoprazan-based therapies were effective and well tolerated for the treatment of...
Objective Vonoprazan (VPZ), clarithromycin (CAM), metronidazole (MNZ) and VPZ, MNZ, and sitafloxacin (STFX) regimen are all established Helicobacter pylori eradication therapies for patients with peni...
Dual priming oligonucleotide-based multiplex polymerase chain reaction (DPO-PCR) has recently been used for both the detection of...
We retrospectively analyzed the electronic medical records of 184 patients who, between September 2019 and December 2020, received eradication therapy following detection of...
In the clarithromycin susceptible group, per-protocol analyses showed eradication rates of 87.5% (42/48; 95% confidence interval [CI], 77.1% to 95.8%) for 7-day therapy and 87.2% (41/47; 95% CI, 78.7%...
Compared to the 14-day therapy, 7-day eradication therapy is sufficient after DPO-PCR-based clarithromycin susceptibility testing....
Due to increasing antibiotic resistance, various Helicobacter pylori eradication regimens other than clarithromycin-based therapies have been proposed. However, detailed data on which therapies were e...
In this retrospective cohort study, we analysed data of 1721 patients and included 608 patients undergoing H. pylori eradication therapy at the Department of Gastroenterology at the University Hospita...
The most common therapy scheme (71% of all cases) was proton pump inhibitor (PPI)-amoxicillin-metronidazole, followed by PPI-amoxicillin-clarithromycin (21%) and PPI-metronidazole-clarithromycin (6%)....
Despite increasing clarithromycin resistance globally, there was no difference in the eradication success of clarithromycin- and non-clarithromycin-containing therapy regimens in Switzerland. As varyi...
Rosacea is a chronic inflammatory skin disease with a high incidence, and it leads to negative emotions such as inferiority complex, increased psychological pressure, and a greatly reduced quality of ...
Clarithromycin extended-release (CLA-ER) was used as companion drug to rifampicin (RIF) for Mycobacterium ulcerans infection in the intervention arm of a WHO drug trial. RIF enhances CYP3A4 metabolism...
Point mutations in the...
The impacts of water chemistry properties including pH and dissolved organic carbon (DOC) on the ecotoxicity of active pharmaceutical ingredients (APIs) are increasingly evident. These impacts are a r...
Macrolide antibiotics are widely used to treat various infections such as pneumonia and sinusitis, and previous exposure to macrolides is presumed to be a risk factor for standard triple therapy failu...
From the Korea National Health Insurance Service (NHIS2021-1-775) database, a total of 46,160 patients who were tested for clarithromycin resistance of H. pylori from 2016 to 2019 in Korea were identi...
Clarithromycin resistance rate of H. pylori in Korea was 16.2%. A multivariate analysis revealed that female sex (OR: 1.472, p < .001), age > 50 years (OR: 1.340, p < .001), previous use of macrolide ...
The use of macrolide antibiotics and a recent diagnosis of respiratory disease might increase clarithromycin resistance of H. pylori....